跳转至内容
Merck
CN
所有图片(1)

文件

MAB3890

Sigma-Aldrich

抗-PPARα抗体

ascites fluid, Chemicon®

别名:

PPAR alpha

登录查看公司和协议定价


About This Item

UNSPSC代码:
12352203
eCl@ss:
32160702
NACRES:
NA.41

生物来源

mouse

质量水平

抗体形式

ascites fluid

抗体产品类型

primary antibodies

克隆

monoclonal

种属反应性

human, mouse

制造商/商品名称

Chemicon®

技术

ELISA: suitable
immunocytochemistry: suitable
western blot: suitable

同位素/亚型

IgG2a

UniProt登记号

运输

dry ice

靶向翻译后修饰

unmodified

基因信息

human ... PPARA(5465)

一般描述

过氧化物酶体增殖物激活受体(PPAR)是核激素受体,可以被多种化合物激活,包括原纤维、噻唑烷二酮、前列腺素和脂肪酸。已经描述了三种PPAR亚型,称为PPARα、PPARβ(也称为PPARδ)和PPARγ。PPAR通过与类固醇受体的类视黄醇X受体(RXR)家族成员形成异二聚体并与称为PPAR反应元件(PPRE)的特定DNA基序结合来促进转录。PPARα在原代肝细胞中含量很高,它调节参与脂肪酸代谢的蛋白质的表达。PPARβ是分布最广泛的亚型,通常以高水平表达。PPARγ主要存在于脂肪组织中,在调节脂肪细胞分化中起关键作用。

特异性

与过氧化物酶体增殖物激活受体α(PPARalpha)反应。与PPARbeta或PPARgamma无交叉反应。

免疫原

来自小鼠PPARalpha氨基酸18-34的合成肽。

应用

使用经ELISA、WB、ICC验证的抗PPAR α抗体(小鼠单克隆抗体)检测PPAR alpha,也称为过氧化物酶体增殖物激活受体α。
研究子类别
转录因子
研究类别
表观遗传学&核功能
蛋白质印迹:1:500-1:5000

免疫细胞化学:1:500-1:5000

ELISA:1:500-1:5,000

最佳工作稀释度必须由最终用户确定。

外形

腹水液。 液体。不含防腐剂。

储存及稳定性

接收后,以未稀释的等分试样在-20°C下保存长达6个月。应避免反复冻/融循环。

分析说明

对照
3T3全细胞裂解物

法律信息

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

免责声明

除非我们的目录或产品随附的其他公司文件中另有说明,否则我们的产品预期仅用于研究用途,不得用于任何其他目的,包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或对人类或动物的任何类型的消费或应用。

Not finding the right product?  

Try our 产品选型工具.

WGK

WGK 1

闪点(°F)

Not applicable

闪点(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Hao-Yu Liu et al.
Frontiers in nutrition, 8, 711398-711398 (2021-11-02)
Scope: Disruptions of circadian rhythm cause metabolic disorders and are closely related to dietary factors. In this study, we investigated the interplays between the dietary conjugated linoleic acid (CLA)-induced hepatic steatosis and the circadian clock regulation, in association with lipid
Demin Cai et al.
Journal of cellular physiology, 236(6), 4387-4402 (2020-11-14)
Nonalcoholic-fatty-liver-disease (NAFLD) is the result of imbalances in hepatic lipid partitioning and is linked to dietary factors. We demonstrate that conjugated linoleic acid (CLA) when given to mice as a dietary supplement, induced an enlarged liver, hepatic steatosis, and increased
Malin Tordis Meyer et al.
International journal of molecular sciences, 22(15) (2021-08-08)
Salivary gland cancers are rare but aggressive tumors that have poor prognosis and lack effective cure. Of those, parotid tumors constitute the majority. Functioning as metabolic machinery contributing to cellular redox balance, peroxisomes have emerged as crucial players in tumorigenesis.
Bo Li et al.
Journal of molecular endocrinology, 53(3), 393-403 (2014-10-15)
The prevalence of non-alcoholic fatty liver disease (NAFLD), a condition characterized by an excessive accumulation of triglycerides (TGs) in hepatocytes, has dramatically increased globally during recent decades. MicroRNAs (miRs) have been suggested to play crucial roles in many complex diseases
Hao-Yu Liu et al.
Liver international : official journal of the International Association for the Study of the Liver, 42(6), 1449-1466 (2022-02-21)
Disruption of lipid metabolism is largely linked to metabolic disorders, such as hypercholesterolemia (HCL) and liver steatosis. While cholesterol metabolic re-programmers can serve as targets for relevant interventions. Here we explored the dietary conjugated linoleic acids (CLA)-induced HCL in mice

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门